UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004227 |
|---|---|
| Receipt number | R000005081 |
| Scientific Title | Phase II study of erlotinib as third-line monotherapy in patients with advanced non-small cell lung cancer |
| Date of disclosure of the study information | 2010/09/17 |
| Last modified on | 2011/03/17 13:08:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/09/17 09:37:13 | ||
| 2 | Update | 2010/09/27 13:13:50 | Interventions/Control_1 Interventions/Control_1 |
|
| 3 | Update | 2011/03/17 13:08:02 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
